Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides

Bibliographic Details
Main Authors:	Robson, J, Doll, H, Suppiah, R, Flossmann, O, Harper, L, Hoglund, P, Jayne, D, Mahr, A, Westman, K, Luqmani, R
Format:	Conference item
Published:	2013

Similar Items

Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials.
by: Robson, J, et al.
Published: (2014)

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials.
by: Robson, J, et al.
Published: (2015)

Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
by: Robson, J, et al.
Published: (2015)

TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
by: Robson, J, et al.
Published: (2013)

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
by: Mukhtyar, C, et al.
Published: (2006)

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
by: Flossmann, O, et al.
Published: (2006)

FACTORS ASSOCIATED WITH LONG-TERM DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF COHORTS FROM THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
by: Robson, J, et al.
Published: (2013)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
by: Mukhtyar, C, et al.
Published: (2008)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
by: Walsh, M, et al.
Published: (2011)

Impact of Cardiovascular Risk Factors on the Occurrence of Cardiovascular Events in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitides
by: Camille Roubille, et al.
Published: (2021-05-01)

Antineutrophil cytoplasmic antibodies
by: G.D. Sebastiani
Published: (2011-06-01)

INTERLEUKIN-23 IN PATIENTS WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED SYSTEMIC VASCULITIDES: THE AUTHORS’ RESULTS AND A REVIEW OF LITERATURE
by: T. V. Beketova, et al.
Published: (2015-10-01)

Antineutrophil cytoplasmic antibodies in autoimmune hepatitis.
by: Bansi, D, et al.
Published: (1995)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
by: de Groot, K, et al.
Published: (2009)

Goodpasture's syndrome with antineutrophil cytoplasmic antibodies
by: Losada, E, et al.
Published: (1993)

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
by: Robson, J, et al.
Published: (2017)

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis
by: Morishita, K, et al.
Published: (2017)

Clinical and biological assessment in systemic necrotizing vasculitides.
by: Mukhtyar, C, et al.
Published: (2006)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
by: Mukhtyar, C, et al.
Published: (2008)

A Tangled Autoimmune Trio: Multiple Sclerosis, Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antineutrophil Cytoplasmic Antibody Vasculitis
by: Rajaie Namas, et al.
Published: (2023-10-01)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
by: De Groot, K, et al.
Published: (2005)

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
by: Megan M. Sullivan, et al.
Published: (2024-01-01)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis
by: Chand, S, et al.
Published: (2013)

Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
by: Harper, L, et al.
Published: (2004)

Characterisation of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis
by: Cameron, B, et al.
Published: (1998)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
by: Suppiah, R, et al.
Published: (2011)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
by: Talks, S, et al.
Published: (1994)

Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
by: Bansi, D, et al.
Published: (1996)

the role of antineutrophil cytoplasmic antibodies in patients with systemic lupus erthematosus
by: mohammed S. Made, et al.
Published: (2006-01-01)

Antineutrophil cytoplasmic autoantibodies in uveitis
by: "Vodjgani M, et al.
Published: (2000-11-01)

ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AFTER LIVER-TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS
by: Bansi, D, et al.
Published: (1995)

Ongoing european research initiatives in systemic vasculitides: The EUVAS program
by: Luqmani, R, et al.
Published: (2005)

Classification criteria for the anca-associated vasculitides
by: Robson, J, et al.
Published: (2019)

State of the art in the treatment of systemic vasculitides.
by: Luqmani, R
Published: (2014)

Patient perceptions of glucocorticoids in anti-neutrophil cytoplasmic antibody-associated vasculitis
by: Robson, J, et al.
Published: (2017)

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives
by: Zdenka Hruskova, et al.
Published: (2020-02-01)

IGG SUBCLASS DISTRIBUTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES IN PRIMARY SCLEROSING CHOLANGITIS AND ULCERATIVE-COLITIS
by: Bansi, D, et al.
Published: (1995)

Introduction to, and classification of, the systemic vasculitides.
by: Luqmani, R, et al.
Published: (2001)

Large vessel vasculitides: update for the cardiologist.
by: Luqmani, R
Published: (2012)

Assessing disease activity in the systemic vasculitides.
by: Luqmani, R
Published: (2002)